Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 2
2015 3
2016 2
2017 2
2019 2
2020 3
2021 5
2022 4
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
RUNX1 as a recombinase cofactor.
Cieslak A, Payet-Bornet D, Asnafi V. Cieslak A, et al. Oncotarget. 2015 Sep 8;6(26):21793-4. doi: 10.18632/oncotarget.5488. Oncotarget. 2015. PMID: 26393399 Free PMC article. No abstract available.
TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2.
Balducci E, Steimlé T, Smith C, Villarese P, Feroul M, Payet-Bornet D, Kaltenbach S, Couronné L, Lhermitte L, Touzart A, Dourthe ME, Simonin M, Baruchel A, Dombret H, Ifrah N, Boissel N, Nadel B, Macintyre E, Cieslak A, Asnafi V. Balducci E, et al. Among authors: cieslak a. Mol Cancer. 2023 Jul 10;22(1):108. doi: 10.1186/s12943-023-01794-y. Mol Cancer. 2023. PMID: 37430263 Free PMC article.
A conserved transcriptional program for MAIT cells across mammalian evolution.
Bugaut H, El Morr Y, Mestdagh M, Darbois A, Paiva RA, Salou M, Perrin L, Fürstenheim M, du Halgouet A, Bilonda-Mutala L, Le Gac AL, Arnaud M, El Marjou A, Guerin C, Chaiyasitdhi A, Piquet J, Smadja DM, Cieslak A, Ryffel B, Maciulyte V, Turner JMA, Bernardeau K, Montagutelli X, Lantz O, Legoux F. Bugaut H, et al. Among authors: cieslak a. J Exp Med. 2024 Feb 5;221(2):e20231487. doi: 10.1084/jem.20231487. Epub 2023 Dec 20. J Exp Med. 2024. PMID: 38117256
PHF6-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax.
Pinton A, Courtois L, Doublet C, Cabannes-Hamy A, Andrieu G, Smith C, Balducci E, Cieslak A, Touzart A, Simonin M, Lhéritier V, Huguet F, Balsat M, Dombret H, Rousselot P, Spicuglia S, Macintyre E, Boissel N, Asnafi V. Pinton A, et al. Among authors: cieslak a. Clin Cancer Res. 2024 Jan 5;30(1):94-105. doi: 10.1158/1078-0432.CCR-23-2159. Clin Cancer Res. 2024. PMID: 37889114
Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancers.
Mikulasova A, Kent D, Trevisan-Herraz M, Karataraki N, Fung KTM, Ashby C, Cieslak A, Yaccoby S, van Rhee F, Zangari M, Thanendrarajan S, Schinke C, Morgan GJ, Asnafi V, Spicuglia S, Brackley CA, Corcoran AE, Hambleton S, Walker BA, Rico D, Russell LJ. Mikulasova A, et al. Among authors: cieslak a. Genome Res. 2022 Jul;32(7):1343-1354. doi: 10.1101/gr.276042.121. Epub 2021 Dec 21. Genome Res. 2022. PMID: 34933939 Free PMC article.
Dynamics of broad H3K4me3 domains uncover an epigenetic switch between cell identity and cancer-related genes.
Belhocine M, Simonin M, Abad Flores JD, Cieslak A, Manosalva I, Pradel L, Smith C, Mathieu EL, Charbonnier G, Martens JHA, Stunnenberg HG, Maqbool MA, Mikulasova A, Russell LJ, Rico D, Puthier D, Ferrier P, Asnafi V, Spicuglia S. Belhocine M, et al. Among authors: cieslak a. Genome Res. 2022 Jul;32(7):1328-1342. doi: 10.1101/gr.266924.120. Epub 2021 Jun 23. Genome Res. 2022. PMID: 34162697 Free PMC article.
ALK-transformed mature T lymphocytes restore early thymus progenitor features.
Congras A, Hoareau-Aveilla C, Caillet N, Tosolini M, Villarese P, Cieslak A, Rodriguez L, Asnafi V, Macintyre E, Egger G, Brousset P, Lamant L, Meggetto F. Congras A, et al. Among authors: cieslak a. J Clin Invest. 2020 Dec 1;130(12):6395-6408. doi: 10.1172/JCI134990. J Clin Invest. 2020. PMID: 33141118 Free PMC article.
Targeting IRAK1 in T-cell acute lymphoblastic leukemia.
Dussiau C, Trinquand A, Lhermitte L, Latiri M, Simonin M, Cieslak A, Bedjaoui N, Villarèse P, Verhoeyen E, Dombret H, Ifrah N, Macintyre E, Asnafi V. Dussiau C, et al. Among authors: cieslak a. Oncotarget. 2015 Aug 7;6(22):18956-65. doi: 10.18632/oncotarget.4150. Oncotarget. 2015. PMID: 26068967 Free PMC article.
PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL.
Andrieu GP, Kohn M, Simonin M, Smith CL, Cieslak A, Dourthe MÉ, Charbonnier G, Graux C, Huguet F, Lhéritier V, Dombret H, Spicuglia S, Rousselot P, Boissel N, Asnafi V. Andrieu GP, et al. Among authors: cieslak a. Blood. 2021 Nov 11;138(19):1855-1869. doi: 10.1182/blood.2020010081. Blood. 2021. PMID: 34125178 Free PMC article. Clinical Trial.
Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients.
Balducci E, Kaltenbach S, Villarese P, Duroyon E, Zalmai L, Friedrich C, Suarez F, Marcais A, Bouscary D, Decroocq J, Birsen R, Fontenay M, Templé M, Brouzes C, Touzart A, Steimlé T, Cieslak A, Lhermitte L, Almire C, Chapuis N, Hermine O, Asnafi V, Kosmider O, Couronné L. Balducci E, et al. Among authors: cieslak a. Blood Cancer J. 2022 Sep 2;12(9):126. doi: 10.1038/s41408-022-00718-1. Blood Cancer J. 2022. PMID: 36055992 Free PMC article. No abstract available.
23 results